You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 1
  • P09.10 Dysregulated Expressions of Inhibitory Checkpoint Molecules and Their Ligands on T-Cells and Blasts in AML Relapses After Stem Cell Transplantation (SCT)

Article info

Article menu

Download PDFPDF

Poster Presentations
P09 Young researchers session
P09.10 Dysregulated Expressions of Inhibitory Checkpoint Molecules and Their Ligands on T-Cells and Blasts in AML Relapses After Stem Cell Transplantation (SCT)
Free

Authors

Citation

Bohlscheid S, Filipini Velazquez G, Aslan H, et al
P09.10 Dysregulated Expressions of Inhibitory Checkpoint Molecules and Their Ligands on T-Cells and Blasts in AML Relapses After Stem Cell Transplantation (SCT)
Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-ITOC9.66

Publication history

  • First published September 21, 2022.
Online issue publication 
September 21, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.